ClinicalTrials.Veeva

Menu

Air Barrier System for the Prevention of Prosthesis-related Infections

N

Nimbic Systems

Status

Unknown

Conditions

Prosthesis-Related Infections

Treatments

Device: ABS deployed and NOT active
Device: ABS deployed and active

Study type

Interventional

Funder types

Industry

Identifiers

NCT02376153
ABS004-H-35894

Details and patient eligibility

About

This is a prospective, randomized, blinded clinical trial to determine if the Air Barrier System device reduces the incidence of surgical site infection after total hip replacement, acetabular repair, posterior spinal fusion, and prosthetic vascular graft procedures.

Full description

This project is an evaluation of a novel device, the Air Barrier System (ABS), to reduce the risk of prosthesis-related surgical site infection in a multi-center clinical trial. The ABS shields surgical incisions intra-operatively by creating a field of high-purity air surrounding an incision that prevents airborne microorganisms from entering the incision.

This research will evaluate ABS performance in a prospective, randomized, blinded multi-center trial. The surgical procedures studied will include total hip arthroplasty, trauma-related acetabula reconstruction, posterior instrumented spine fusion, and prosthetic vascular graft procedures. Patients will be enrolled during the first two years of the study, and CDC guidelines require a one year follow-up period to monitor patients for potential prosthesis-related infections.

Enrollment

816 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Total hip arthroplasty;
  • Acetabular repair with instrumentation;
  • Posterior lumbar, cervical, or thoracic (up to and including 6 vertebral levels) spine fusion with instrumentation and vascular prosthetic graft implantation.

Exclusion criteria

  • History of prior prosthesis infection;
  • Active infection;
  • Open traumatic wounds as is the case after some acetabular fractures.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

816 participants in 2 patient groups

ABS deployed and active
Experimental group
Description:
Air Barrier System (ABS) will be deployed onto the surgical field and activated.
Treatment:
Device: ABS deployed and active
ABS deployed and NOT active
Sham Comparator group
Description:
Air Barrier System (ABS) will be deployed onto the surgical field and NOT activated. This is a sham comparator to reduce the influence of the presence of the device and provide user blinding.
Treatment:
Device: ABS deployed and NOT active

Trial contacts and locations

1

Loading...

Central trial contact

Sean Self; Kylie Pflieger

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems